Effect of oral supplementation with different energy boosters in newborn piglets on pre-weaning mortality, growth and serological levels of IGF-I and IgG.
Oral supplements are commonly used in commercial herds to improve energy status and passive immune acquisition of newborn piglets. However, there is little scientific evidence on the efficacy of oral supplements for piglets. The objective of this experiment was to study the effects of 2 oral supplementation products on piglet pre-weaning mortality and growth. A total of 62 litters (749 piglets) were distributed according to the sow's parity among 3 treatments: 1) CONTROL group, no oral supplementation to piglets; 2) EN group, light piglets (LP: birth BW ≤ 1.35 kg) received 2 doses of 1 mL Lianol Colostro; 3) COLO group, LP received 2 doses of 5 mL ColoBoost. Treatments were administered within 4 h after birth and repeated 8 h after the first dose. Piglets were weighed at d 0, 1, 10, and 21 after birth. Piglet rectal temperature was recorded shortly after birth and at 24 h. Cross-fostering was performed 24 h after birth. Blood samples were obtained from 39 LP at d 5 and 21 to determine IGF-I and IgG levels. Total mortality and LP mortality rate (percentage of LP in the litter that died) were recorded. At d 1, the EN group had a lower total mortality rate (2.1 vs. 7.1 ± 1.4%, = 0.036) and LP mortality rate (4.5 vs. 11.1 ± 2.8%, = 0.047) than the CONTROL group. At d 1, the COLO group tended to have a lower LP mortality rate than the CONTROL group (8.4 vs. 11.1 ± 3.0%, = 0.058). After cross-fostering, the COLO group had a lower LP mortality rate at d 21 than the CONTROL group (6.3 vs. 18.3 ± 2.8%, = 0.043). The total mortality rate and piglet body weight did not differ among groups at d 21. Piglets in the COLO group had a higher IgG level at d 5 than those in the EN group (24.9 vs. 16.3 ± 2.15 mg/mL, = 0.034) and tended to be higher than those in the CONTROL group (24.9 vs. 17.7 ± 2.35 mg/mL, = 0.072). Piglets in the EN group had a higher serum IGF-I concentration than those in the CONTROL group at d 21 (137.6 vs. 100.3 ± 11.15 ng/mL, = 0.030). The results suggested that 2 doses of oral supplementation within 12 h after birth might be effective in increasing small piglet survival and improving their IGF-I or IgG levels during lactation without compromising litter growth.
R
R
Muns
M
M
Nuntapaitoon
P
P
Tummaruk
D000818:Animals; D000831:Animals, Newborn; D019587:Dietary Supplements; D005260:Female; D007074:Immunoglobulin G / Q000097:blood*; D007334:Insulin-Like Growth Factor I / Q000378:metabolism*; D011247:Pregnancy; D013552:Swine / Q000254:growth & development / Q000502:physiology*
D007074:Immunoglobulin G; D007334:Insulin-Like Growth Factor I